NASDAQ:ICU

Seastar Medical Holding Stock News

etoro logo Buy ICU
*Your capital is at risk
$3.28
-0.250 (-7.08%)
At Close: Jun 03, 2026
DENVER, Nov. 17, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing
Business highlights include: Three new top-rated children's hospitals adopt QUELIMMUNE therapy for ultra-rare pediatric Acute Kidney Injury (AKI) Commercial use of QUELIMMUNE therapy demonstrates posi
SAN JOSE, CALIFORNIA / ACCESS Newswire / November 11, 2025 / VSee Health, Inc. (Nasdaq:VSEE) a leader in HIPAA-compliant telemedicine solutions, leveraging its newly secured FedRAMP Moderate authoriza
SeaStar Medical Holding Corporation (NASDAQ: ICU - Get Free Report) shares dropped 2.7% during mid-day trading on Wednesday. The company traded as low as $0.4220 and last traded at $0.5062. Approximat
DENVER, Nov. 05, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing
AlphaQuest LLC boosted its holdings in ICU Medical, Inc. (NASDAQ: ICUI) by 3,058.3% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commi
ICU Medical, Inc. (NASDAQ: ICUI - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the six brokerages that are presently covering the firm, MarketBeat reports. One equitie
Shares in Ondine Biomedical Inc (AIM:OBI, OTC:OBIMF) climbed 4% to 13p, extending their year-to-date gain to 44%, after the company reported encouraging results from its Steriwave ICU Pilot Study at R
SAN CLEMENTE, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of
KLP Kapitalforvaltning AS grew its position in shares of ICU Medical, Inc. (NASDAQ: ICUI) by 8.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commis
Data show results consistent with clinical trial experience A high level of safety – no device-related adverse events Strong survival data extending to 90 days
Independent DSMB reports zero device-related safety issues Supports potential clinical benefit Trial sample size re-estimated to strengthen statistical power
DENVER, Sept. 23, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company, announced today that preliminary results from the SAVE Surveillance
DENVER, Sept. 04, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facin
DENVER, Sept. 02, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facin
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE